Philip Hallenborg

2.1k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

Philip Hallenborg is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Philip Hallenborg has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Physiology and 7 papers in Oncology. Recurrent topics in Philip Hallenborg's work include Adipose Tissue and Metabolism (10 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Liver Disease Diagnosis and Treatment (4 papers). Philip Hallenborg is often cited by papers focused on Adipose Tissue and Metabolism (10 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Liver Disease Diagnosis and Treatment (4 papers). Philip Hallenborg collaborates with scholars based in Denmark, Norway and Sweden. Philip Hallenborg's co-authors include Karsten Kristiansen, Lise Madsen, Rasmus K. Petersen, Blagoy Blagoev, Claus Jørgensen, Vyacheslav Akimov, Michele Puglia, Inigo Barrio‐Hernandez, Irina Kratchmarova and Jacob B. Hansen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Philip Hallenborg

25 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites

2018 339 citations Vyacheslav Akimov, Inigo Barrio‐Hernandez et al. Nature Structural & Molecular Biology profile →

Peers

Philip Hallenborg

PHYSI

EPIDE

ONCOL

Pierre‐Damien Denechaud France

Raquel Fucho Spain

Eric Holle United States

Franklin Liu United States

Sarah Hummasti United States

Wissal El-Assaad Canada

M. Mahmood Hussain United States

Banumathi K. Cole United States

Anna Baulies Spain

Zhiqiang Li United States

Pierre‐Damien Denechaud France

Philip Hallenborg

1.2k ×1.3

428 ×0.8

PHYSI

609 ×1.5

EPIDE

166 ×0.8

ONCOL

271 ×1.5

Citations per year, relative to Philip Hallenborg Philip Hallenborg (= 1×) peers Pierre‐Damien Denechaud

Countries citing papers authored by Philip Hallenborg

Since Specialization

Citations

This map shows the geographic impact of Philip Hallenborg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Hallenborg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Hallenborg more than expected).

Fields of papers citing papers by Philip Hallenborg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Hallenborg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Hallenborg. The network helps show where Philip Hallenborg may publish in the future.

Co-authorship network of co-authors of Philip Hallenborg

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Hallenborg. A scholar is included among the top collaborators of Philip Hallenborg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Hallenborg. Philip Hallenborg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akimov, Vyacheslav, Charlotte Wilhelmina Wernberg, Philip Hallenborg, et al.. (2025). Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease. Communications Medicine. 5(1). 56–56. 6 indexed citations

Wang, Lin, Zhuohao Liu, Dewei Ye, et al.. (2022). Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation. Advanced Science. 9(20). e2200742–e2200742. 29 indexed citations

Hallenborg, Philip, Benjamin A. H. Jensen, Even Fjære, et al.. (2021). Adipose MDM2 regulates systemic insulin sensitivity. Scientific Reports. 11(1). 21839–21839. 8 indexed citations

Veidal, Sanne Skovgård, Michael Feigh, Philip Hallenborg, et al.. (2020). Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis. Scientific Reports. 10(1). 1148–1148. 41 indexed citations

Barrio‐Hernandez, Inigo, Abbas Jafari, Kristoffer Rigbolt, et al.. (2019). Phosphoproteomic profiling reveals a defined genetic program for osteoblastic lineage commitment of human bone marrow–derived stromal stem cells. Genome Research. 30(1). 127–137. 13 indexed citations

Akimov, Vyacheslav, Inigo Barrio‐Hernandez, Philip Hallenborg, et al.. (2018). UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nature Structural & Molecular Biology. 25(7). 631–640. 339 indexed citations breakdown →

Li, Xiaomu, Kenneth K.Y. Cheng, Zhuohao Liu, et al.. (2016). The MDM2–p53–pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic β-cells. Nature Communications. 7(1). 11740–11740. 49 indexed citations

Hallenborg, Philip, Majken Siersbæk, Inigo Barrio‐Hernandez, et al.. (2016). MDM2 facilitates adipocyte differentiation through CRTC-mediated activation of STAT3. Cell Death and Disease. 7(6). e2289–e2289. 24 indexed citations

Hallenborg, Philip, Rasmus K. Petersen, Irene Kouskoumvekaki, et al.. (2015). The elusive endogenous adipogenic PPARγ agonists: Lining up the suspects. Progress in Lipid Research. 61. 149–162. 36 indexed citations

10.

Hallenborg, Philip, Even Fjære, Bjørn Liaset, et al.. (2015). p53 regulates expression of uncoupling protein 1 through binding and repression of PPARγ coactivator-1α. American Journal of Physiology-Endocrinology and Metabolism. 310(2). E116–E128. 30 indexed citations

11.

Hallenborg, Philip, Rasmus K. Petersen, Søren Feddersen, et al.. (2014). PPARγ ligand production is tightly linked to clonal expansion during initiation of adipocyte differentiation. Journal of Lipid Research. 55(12). 2491–2500. 22 indexed citations

12.

Hallenborg, Philip, Søren Feddersen, Sarah Francoz, et al.. (2012). Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation. Cell Death and Differentiation. 19(8). 1381–1389. 37 indexed citations

13.

Liaset, Bjørn, Qin Hao, Henry Jørgensen, et al.. (2011). Nutritional Regulation of Bile Acid Metabolism Is Associated with Improved Pathological Characteristics of the Metabolic Syndrome. Journal of Biological Chemistry. 286(32). 28382–28395. 58 indexed citations

14.

Hallenborg, Philip, Claus Jørgensen, Rasmus K. Petersen, et al.. (2010). Epidermis-Type Lipoxygenase 3 Regulates Adipocyte Differentiation and Peroxisome Proliferator-Activated Receptor γ Activity. Molecular and Cellular Biology. 30(16). 4077–4091. 43 indexed citations

15.

Hallenborg, Philip, Søren Feddersen, Lise Madsen, & Karsten Kristiansen. (2009). The tumor suppressors pRB and p53 as regulators of adipocyte differentiation and function. Expert Opinion on Therapeutic Targets. 13(2). 235–246. 48 indexed citations

16.

Hao, Qin, Jacob B. Hansen, Rasmus K. Petersen, et al.. (2009). ADD1/SREBP1c activates the PGC1-α promoter in brown adipocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1801(4). 421–429. 24 indexed citations

17.

Liaset, Bjørn, Lise Madsen, Qin Hao, et al.. (2009). Fish protein hydrolysate elevates plasma bile acids and reduces visceral adipose tissue mass in rats. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1791(4). 254–262. 104 indexed citations

18.

Petersen, Rasmus K., Lise Madsen, Lone Møller Pedersen, et al.. (2008). Cyclic AMP (cAMP)-Mediated Stimulation of Adipocyte Differentiation Requires the Synergistic Action of Epac- and cAMP-Dependent Protein Kinase-Dependent Processes. Molecular and Cellular Biology. 28(11). 3804–3816. 135 indexed citations

19.

Madsen, Lise, Rasmus K. Petersen, Knut R. Steffensen, et al.. (2008). Activation of Liver X Receptors Prevents Statin-induced Death of 3T3-L1 Preadipocytes. Journal of Biological Chemistry. 283(33). 22723–22736. 5 indexed citations

20.

Fürstenberger, Gerhard, Katja‐Martina Eckl, Hans Christian Hennies, et al.. (2006). Role of epidermis-type lipoxygenases for skin barrier function and adipocyte differentiation. Prostaglandins & Other Lipid Mediators. 82(1-4). 128–134. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact